Consistent with previous studies [11–14], we also identified checkpoint kinase 1 (CHK1) inhibitors as GEM-sensitizing PKIs in pancreatic cancer MIA PaCa-2 cells [7]. Here, CHEK1 is linked to familial pancreatic carcinoma.